Clinical Study of Effects of Targeting Therapy with Iodine-131 Labeled Monoclonal Antibody for Hepatocellular Carcinoma
- VernacularTitle:~(131)I标记单克隆抗体导向治疗肝癌的临床研究进展
- Author:
Quanjun YAO
;
Wusheng LU
- Publication Type:Journal Article
- Keywords:
Iodine-131 Monoclonal antibody Targeting therapy Hepatocellular carcinoma
- From:
Chinese Journal of Bases and Clinics in General Surgery
2003;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical effects of targeting therapy with iodine-131 labeled monoclonal antibody for hepatocellular carcinoma(HCC).Methods The related published literatures were reviewed and summarized.Results The reasonable application of targeting therapy with iodine-131 labeled monoclonal antibody could improve the prognosis for patients with HCC especially for some primary HCC.It was used in various kinds of HCC patients with no severe side effects.Conclusion The targeting therapy with iodine-131 labeled monoclonal antibody may be considered as a safe and effective method to treat HCC and an adjuvant therapy for liver surgery.
